Siemens nv / SA - Corporate website Siemens …...A91SY-9136-A1-7600 Revolutionizing image reading...
1
A91SY-9136-A1-7600 Revolutionizing image reading and evaluation in oncology Cancer is a threat to the entire body. That is why the imaging software syngo.via from Siemens supports a multi-modality approach to help maximize therapeutic outcomes. Interdisciplinary imaging studies – such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans – have become standard in oncology diagnostic evaluations. Furthermore, for a clinical institution to be successful, it is essential to obtain the highest possible diagnostic accuracy. To stay competitive, however, a facility also has to maintain a fast and efficient oncology workflow. syngo.via 2 creates an exciting experience in efficiency and ease of use – with a unique combina- tion of innovative features and applica- tions tailored to the oncology workflow. A sophisticated software solution for every step of the oncology workflow On up to two monitors, syngo.via pro- vides a seamless integration of quantitative measures, automated processes, and ad- vanced visualization into your oncology reading workflow. For example, it com- bines 3 accurate and fast lesion segmen- tation, RECIST 1.0 and WHO calculation, automated lesion finding and tracking, and multi-modality reading. A number of quantitative parameters characterizing a segmented lesion are provided 3 to fulfill clinical care as well as research require- ments. The tumor growth rates and tumor burden can be calculated automatically. And computer-aided detection (CAD) 4 tools can be integrated as a second reader to help you increase diagnostic confidence, while maintaining a fast and efficient workflow. 1 Regulatory clearance with syngo.PET&CT Oncology. 2 syngo.via can be used as a standalone device or together with a variety of cleared and unmodified syngo.via-based software options, which are medical devices in their own rights. 3 This functionality belongs to the syngo.via-based software applications syngo.PET&CT Oncology and syngo.MR Onco Engine. 4 syngo.CXR CAD is not available for sale in the U.S. 5 If minimum hardware requirements are met. 6 Prerequisites include: Internet connection to clinical network, DICOM compliance, meeting of minimum hardware requirements, and adherence to local data security regulations. syngo.via, MultiModality Compare syngo.PET Segmentation 1 syngo.MR Onco syngo.CT Segmentation 1 Innovative integration Diagnosis Treatment Follow-up Diagnosis • Efficient image and hybrid studies reading • Diagnostic confidence • Precise tumor quantification Treatment • Support selection of treatment modality • Aid therapy prognosis Follow-up • Monitor treatment response • Efficient lesion tracking • Reproducible measurements Finding, not searching: Findings Navigator In oncology imaging, keeping track of findings over the entire patient history can sometimes be quite a challenge. Multiple lesions, multiple time-points, and multiple readers can often result in countless findings. As it automatically collects the findings on-the-fly while you are reading a case, syngo.via’s unique Findings Navigator makes referencing and reporting easy. The Findings Navigator thus facilitates accelerated reading and the list of findings can be effectively used as bookmarks during clinical demonstra- tions such as tumor board meetings. More than just processing images syngo.via allows you to experience higher reading efficiency thanks to its client- server technology and integration with your RIS or PACS. Most of the processing and rendering of data from the connected modalities is done by the server while the client provides the user interface – even on off-the-shelf computer hardware 5 . This means that users can access syngo.via from virtually anywhere within the network infrastructure and perform their tasks – whether at a workstation in a different department, at the RIS/PACS reporting workplace, at a tumor board, the reading physician’s office or even at home 6 . www.siemens.com/syngo.via
Transcript of Siemens nv / SA - Corporate website Siemens …...A91SY-9136-A1-7600 Revolutionizing image reading...
A91SY-9136-A1-7600
Revolutionizing image reading and evaluation in oncologyCancer is a threat to the entire body. That is why the imaging software syngo.via from Siemens supports a multi-modality approach to help maximize therapeutic outcomes.
Interdisciplinary imaging studies – such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans – have become standard in oncology diagnostic evaluations. Furthermore, for a clinical institution to be successful, it is essential to obtain the highest possible diagnostic accuracy. To stay competitive, however, a facility also has to maintain a fast and efficient oncology workflow. syngo.via2 creates an exciting experience in efficiency and ease of use – with a unique combina-tion of innovative features and applica-tions tailored to the oncology workflow.
A sophisticated software solution for every step of the oncology workflow
On up to two monitors, syngo.via pro-vides a seamless integration of quantitative measures, automated processes, and ad-vanced visualization into your oncology reading workflow. For example, it com-bines3 accurate and fast lesion segmen-tation, RECIST 1.0 and WHO calculation, automated lesion finding and tracking, and multi-modality reading. A number of quantitative parameters characterizing a segmented lesion are provided3 to fulfill clinical care as well as research require-ments. The tumor growth rates and tumor burden can be calculated automatically. And computer-aided detection (CAD)4 tools can be integrated as a second reader to help you increase diagnostic confidence, while maintaining a fast and efficient workflow.
1 Regulatory clearance with syngo.PET&CT Oncology.2 syngo.via can be used as a standalone device or together with a variety of cleared and unmodified syngo.via-based
software options, which are medical devices in their own rights.3 This functionality belongs to the syngo.via-based software applications syngo.PET&CT Oncology and syngo.MR Onco Engine. 4 �syngo.CXR CAD is not available for sale in the U.S. 5 If minimum hardware requirements are met.6 Prerequisites include: Internet connection to clinical network, DICOM compliance, meeting of minimum hardware
requirements, and adherence to local data security regulations.
syngo.via, MultiModality Compare
syngo.PET Segmentation1
syngo.MR Onco
syngo.CT Segmentation1
Innovative integration
Diagnosis Treatment Follow-up
Diagnosis
• Efficient image and hybrid studies reading
• Diagnostic confidence• Precise tumor quantification
Treatment
• Support selection of treatment modality
• Aid therapy prognosis
Follow-up
• Monitor treatment response• Efficient lesion tracking• Reproducible measurements
Finding, not searching: Findings Navigator
In oncology imaging, keeping track of findings over the entire patient history can sometimes be quite a challenge. Multiple lesions, multiple time-points, and multiple readers can often result in countless findings. As it automatically collects the findings on-the-fly while you are reading a case, syngo.via’s unique Findings Navigator makes referencing and reporting easy. The Findings Navigator thus facilitates accelerated reading and the list of findings can be effectively used as bookmarks during clinical demonstra-tions such as tumor board meetings.
More than just processing images
syngo.via allows you to experience higher reading efficiency thanks to its client-server technology and integration with your RIS or PACS. Most of the processing and rendering of data from the connected modalities is done by the server while the client provides the user interface – even on off-the-shelf computer hardware5. This means that users can access syngo.via from virtually anywhere within the network infrastructure and perform their tasks – whether at a workstation in a different department, at the RIS/PACS reporting workplace, at a tumor board, the reading physician’s office or even at home6.
www.siemens.com/syngo.via
